Childhood adversity linked to elevated health risks, differing by sex and stress

Researchers assess the heterogeneous effects of childhood adversity on disease biomarkers and health conditions in adulthood.

API manufacturer in China handed warning letter after failing to respond to the regulator’s requests for information

An active pharmaceutical ingredient manufacturer in China reportedly lied to the FDA about whether it will continue shipping products into the US and did not

June 28, 2023

Eisai, Biogen make case for long-term use of Alzheimer’s drug Leqembi with new data

Patients with early Alzheimer’s disease treated with a medication developed by Eisai and Biogen for up to three years experienced less cognitive decline than what’s

July 30, 2024

Fulcrum’s Phase 3 for old GSK drug fails, stock sinks

Fulcrum Therapeutics reported a Phase 3 fail Thursday morning, sending its stock plummeting. The biotech said that a study testing the … Sign up to

September 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.